NEO DARBAZINE SPANSULE CAPSULE NO 1 DIN 00151149
Health Canada record
| Active ingredient(s) | PROCHLORPERAZINE MALEATE 5.4 MG; ISOPROPAMIDE IODIDE 1.67 MG; NEOMYCIN SULFATE 25 MG |
|---|---|
| Dosage form | Capsule (Sustained-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | QA07AA51 NEOMYCIN, COMBINATIONS |
| Original market date | 31-Dec-1969 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PROCHLORPERAZINE MALEATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00150983 | DARBAZINE SPANSULE CAPS NO. 1 | NORDEN LABORATORIES INC. | Capsule (Sustained-Release) | PROCHLORPERAZINE MALEATE 5.4 MG; ISOPROPAMIDE IODIDE 1.67 MG | Cancelled Post Market |
| 00150991 | DARBAZINE SPANSULE CAPS NO. 3 | NORDEN LABORATORIES INC. | Capsule (Sustained-Release) | PROCHLORPERAZINE MALEATE 16.21 MG; ISOPROPAMIDE IODIDE 5 MG | Cancelled Post Market |
| 00402672 | NEO DARBAZINE SPANSULE NO3 | NORDEN LABORATORIES INC. | Capsule (Sustained-Release) | PROCHLORPERAZINE MALEATE 16.2 MG; ISOPROPAMIDE IODIDE 6.8 MG; NEOMYCIN SULFATE 107 MG | Cancelled Post Market |
International API supply for PROCHLORPERAZINE MALEATE
1 valid EDQM Certificates of Suitability from 1 holders. 3 active FDA Drug Master Files.
Request a quote for NEO DARBAZINE SPANSULE CAPSULE NO 1